Season 3 Episode 2: Diagnosis and Management of Complement Mediated Kidney Diseases Supported by Novartis

Global Kidney Care Podcast Provided by ISN

Το περιεχόμενο παρέχεται από το ISN, Roberto Pecoits-Filho, and Smeeta Sinha. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον ISN, Roberto Pecoits-Filho, and Smeeta Sinha ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

1+ y ago 40:47

MP3•Αρχική οθόνη επεισοδίου

Drs Namrata Parikh, Gary Chan and Nick Medjeral-Thomas are nephrologists and complement enthusiasts interested in the diagnosis and management of complement mediated kidney diseases. In this conversation, we discussed key clinical and pathology features of inappropriate, pathogenic complement activity that guide physicians to a diagnosis of C3 glomerulopathy. We discussed differences in investigation and management strategies between our respective clinical centers in Ottawa, Hong Kong and London, including access to clinical trials of therapeutic complement inhibitors. To finish, we speculated on the future impact on clinical nephrology of complement pathway analysis and inhibition.
Make sure to also check out the Complement-Mediated Kidney Diseases Toolkit here

43 επεισόδια

#Fitness #Podcasting Education #Medicine #Roberto Pecoits-Filho, Smeeta Sinha #Roberto Pecoits-Filho #Smeeta Sinha